Swadeshi Jagran Manch wants Nachiket Mor to be dropped out of RBI board

Mor is currently National Director for Bill and Melinda Gates Foundation - India

Nachiket Mor, RBI Board
Nachiket Mor | Photo: Twitter@nachiketmor
Press Trust of India New Delhi
Last Updated : Apr 15 2018 | 7:08 PM IST

The RSS-affiliated SJM has written to Prime Minister Narendra Modi demanding removal of Nachiket Mor from the RBI board on grounds of conflict of interest.

..there is no case for retaining Nachiket Mor on the board of Reserve Bank of India (RBI). It is a fit case of conflict of interest, as his principal employer BMGF receives foreign funds and the RBI is regulator of the fund, the Swadeshi Jagran Manch co-convener Ashwani Mahajan said in his letter to Modi.

He further alleged that the activities of Bill and Melinda Gates Foundation (BMGF) are suspicious.

We request you to take stringent action, so that the message must go to all that they can't take India for granted, the letter added.

Mor is full-time India representative of BMGF, which is under strict vigil of the Ministry of Home Affairs and is actively getting funds from foreign sources, Mahajan said in his letter.

The fact that BMGF is functioning in India with RBI's permission makes it a glaring case of conflict of interest, he said.

The Home Ministry is keeping a vigil on BMGF because of the allegations that the foundation is working for multinational companies to influence government policies on health and agriculture sectors in their favour, the SJM said.

The SJM also demanded that instructions must be issued to NITI Aayog, ICMR and the Union ministries of Agriculture, Health and Family Welfare, Finance besides the Women and Child Development to keep such outfits and their representatives at bay.

Mor is currently National Director for Bill and Melinda Gates Foundation - India. He is also the member of the Central Board of the Reserve Bank of India.

There have been some media reports recently, making further allegations that the foundation is funding an NGO, Global Health Strategies or GHS to push globally-redundant vaccines to India, Mahajan said.

"Obviously, this would create more business for certain pharmaceutical companies where BMGF and many of these NGOs have cross funding, but these vaccines will create a negative impact on our fellow Indians," he added.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 15 2018 | 7:08 PM IST

Next Story